Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$493K Buy
54,476
+3,776
+7% +$45.6K ﹤0.01% 3621
2025
Q4
$626K Sell
50,700
-1,748
-3% -$23.3K ﹤0.01% 3576
2025
Q3
$702K Buy
+52,448
New +$717K ﹤0.01% 3538

Other funds holding CARL

Northern Trust's CARL Position: Q1 2026 in Review

Northern Trust increased its Carlsmed (CARL) stake by 7.4% in Q1 2026, buying an estimated $45.6K and bringing the position to 54,476 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #3621.

Northern Trust first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $702K in Q3 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Northern Trust held 54,476 shares of Carlsmed worth $493K as of Q1 2026.
  • Northern Trust bought 3,776 Carlsmed shares in Q1 2026, an estimated $45.6K.
  • Carlsmed made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3621 holding.
  • Northern Trust first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • Northern Trust's Carlsmed position peaked at $702K in Q3 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.